Everyone pretty much knows how the drug has been abused, so would an extended use help the cause? This looks to be a big potential loss
for Abbott if they were counting on the money. BD
The agency sent the drugmaker a ‘complete response letter,’ which is another way of saying its extended-release formation of Vicodin is not being approved.
The new version of Vicodin, by the way, was projected to generate more than $500 million in annual sales.
http://www.pharmalot.com/2008/10/fda-rejects-abbott-labs-painkiller/
0 comments :
Post a Comment